Dr. Merad is a full member of the Immunology Institute.
Tisch Cancer Institute
Dr. Merad is the Program Leader of the Cancer Immunology Immunotherapy at the Tisch Cancer Institute.
Human Immune Monitoring Core
Dr. Merad is the Director of the Immunomonitoring Core at Icahn School of Medicine at Mount Sinai. The center’s mission is to identify novel immune biomarkers of disease and response to therapy in patients with cancer and other immune disease.
Dr. Merad has joined The Immunological Genome (Immgen) Project in 2010. The Immgen consortia combines immunology and computational biology laboratories to provide a complete 'road map' of gene-expression and regulatory networks in all immune cells.
Dr. Merad is an Associate Director of the MD PhD program.
Dr. Merad lectures Core III Fundamentals in Immunology